Cardiac Science Sets Date for Third Quarter, Nine-Month Results Release and Conference Call

Cardiac Science Sets Date for Third Quarter, Nine-Month Results Release and
Conference Call

BOTHELL, Wash., Oct. 29 /PRNewswire-FirstCall/ -- Cardiac Science Corporation
(Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and
diagnostic cardiac monitoring devices, announced today that it will release
its third quarter 2009 financial results on Monday, November 9, 2009 after
market close. The Company has scheduled a conference call with analysts and
investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science
management will discuss the financial results for the third quarter as well as
the current business outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To access the conference call, please dial 877.941.2332 and reference
conference ID 4179087. Callers outside the U.S. can dial 480.629.9724. The
call will also be webcast live at www.cardiacscience.com. An audio replay of
the call will be available for 7 days following the call at 800.406.7325 for
U.S. callers or 303.590.3030 for those calling from outside the U.S. The
password required to access the replay is 4179087#. An archived webcast will
also be available at www.cardiacscience.com for 90 days.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced
diagnostic and therapeutic cardiology devices and systems, including automated
external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac
stress treadmill and systems, Holter monitoring systems, hospital
defibrillators, cardiac rehabilitation telemetry systems, vital signs
monitors, and cardiology data management systems (informatics) that connect
with hospital information (HIS), electronic medical record (EMR), and other
information systems. The company sells a variety of related products and
consumables and provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses that
established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton®
brands, is headquartered in Bothell, Washington. With customers in more than
100 countries worldwide, the company has operations in North America, Europe,
and Asia. For information, call 425.402.2000 or visit
http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac
monitoring, find us on the Cardiac Science blog at
http://www.cardiacscience.com/blog, Twitter at
http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and
YouTube at http://budurl.com/CSonYT.

For more information,
Company Contact: Investor Contact: Media Contact:
---------------- ----------------- --------------
Mike Matysik Matt Clawson Christopher Gale
Cardiac Science Corporation Allen & Caron EVC Group Inc.
Senior Vice President and CFO 949.474.4300 646.201.5431
425.402.2009 matt@allencaron.com 203.570.4681
cgale@evcgroup.com

CSCX-F

SOURCE Cardiac Science Corporation

Company, Mike Matysik, Senior Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; or Investors, Matt Clawson of Allen & Caron,
+1-949-474-4300, matt@allencaron.com; or Media, Christopher Gale of EVC Group
Inc., +1-646-201-5431, +1-203-570-4681, cgale@evcgroup.com, both for Cardiac
Science Corporation